Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Gerresheimer    GXI   DE000A0LD6E6

GERRESHEIMER

(GXI)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Gerresheimer AG : annual earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/11/2019 | 09:15am EST

The company will report its earnings for FY 2018 on 02/14/2019. Generally, the company reports earnings better than estimates. In recent months, the 12 analysts from Thomson Reuters consensus have revised their EPS estimates downward.

Annual earnings per share is expected at 3.69 EUR for 2018 (+ 15.1% from 2017). A summary of annual publications and estimates is available below.

Annual results2015201620172018 (e)2019 (e)
Sales
Million €
Released
Forecast
Spread
1 377
1 382
-0,33%
1 375
1 433
-4,0%
1 348
1 356
-0,60%

1 372

1 447
Operating income (EBITDA)
Million €
Released
Forecast
Spread
278
283
-1,7%
308
317
-2,9%
311
303
2,7%

291

294
Operating profit (EBIT)
Million €
Released
Forecast
Spread
191
177
8,2%
221
207
6,8%
207
185
12%

154

145
Pre-Tax Profit (EBT)
Million €
Released
Forecast
Spread
159
143
11%
147
164
-10%
145
144
1,1%

112

104
Net income
Million €
Released
Forecast
Spread
104
86,8
20%
122
109
12%
101
103
-2,2%

108

71,2
EPS
 €
Released
Forecast
Spread
3,32
2,91
14%
3,87
3,61
7,2%
3,21
3,18
0,79%

3,69

2,33
Announcement Date02/11/201602/15/201702/22/2018

© MarketScreener.com 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GERRESHEIMER
02/14GERRESHEIMER AG : Gerresheimer back on growth path
EQ
02/11GERRESHEIMER AG : annual earnings release
02/04GERRESHEIMER AG : Preliminary announcement of the publication of financial repor..
EQ
01/16PHARMAPACK 2019 : Innovative packaging solutions for the pharmaceutical and heal..
PU
01/02European shares start 2019 shakily as China, EU figures deepen gloom
RE
2018PHARMAPACK 2019 : Gerresheimer to present its first self-developed high-quality ..
PU
2018PHARMAPACK 2019 : Solutions for digital and electronic drug delivery products wi..
PU
2018GERRESHEIMER : Dr. Bernd Metzner to become Chief Financial Officer of Gerresheim..
PU
2018PHARMTECH MOSCOW 2018 : Series production of Gx RTF ClearJect plastic syringes s..
PU
2018GERRESHEIMER AG : Notification and public disclosure of transactions by persons
EQ
More news
Financials (€)
Sales 2019 1 442 M
EBIT 2019 147 M
Net income 2019 72,3 M
Debt 2019 913 M
Yield 2019 1,72%
P/E ratio 2019 24,65
P/E ratio 2020 20,65
EV / Sales 2019 1,99x
EV / Sales 2020 1,86x
Capitalization 1 953 M
Chart GERRESHEIMER
Duration : Period :
Gerresheimer Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GERRESHEIMER
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 71,0 €
Spread / Average Target 14%
EPS Revisions
Managers
NameTitle
Dietmar Siemssen Chief Executive Officer
Axel Herberg Chairman-Supervisory Board
Rainer Beaujean Chief Financial Officer
Theodor Stuth Independent Member-Supervisory Board
Udo J. Vetter Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
GERRESHEIMER8.65%2 206
MEDTRONIC PLC0.30%123 923
BAXTER INTERNATIONAL10.06%39 075
ZIMMER BIOMET HOLDINGS19.22%25 222
HOYA CORPORATION3.55%23 083
TERUMO CORP8.16%22 589